Skip to main content
. 2019 Dec 13;34(5):1315–1328. doi: 10.1038/s41375-019-0677-4

Fig. 7. Theoretical and experimental efficacy of 177Lu-lilotomab alone or combined with G2/M arrest inhibitors in tumor samples from patients with NHL.

Fig. 7

Theoretical (using the Bliss independence mathematical model) and experimental antiproliferative effects of 177Lu-lilotomab and/or MK-1775 or PD-166285 (18 h incubation). The analysis was done at day 1 and day 4 post treatment.